Heart, Lung and Circulation
Volume 16, Issue 1 , Pages 50-51 , February 2007

Late Restenosis Following Placement of a Sirolimus Eluting Stent for In-Stent Restenosis

Received 20 February 2006 ,Accepted 3 August 2006.

Reference 

  1. Limpijankit T, Mehran R, Mintz GS, Dangas G, Lansky AJ, Kao J, et al. Long-term follow-up of patients after gamma intracoronary brachytherapy failure (from GAMMA-I, GAMMA-II, and SCRIPPS-III). Am J Cardiol. 2003;92(3):315–318
  2. Kay IP, Wardeh AJ, Kozuma K, Foley DP, Knook AH, Thury A, et al. Radioactive stents delay but do not prevent in-stent neointimal hyperplasia. Circulation. 2001;103(1):14–17
  3. Schiele TM. Current understanding of coronary in-stent restenosis pathophysiology, clinical presentation, diagnostic work-up, and management. Z Kardiol. 2005;94(11):772–790
  4. Kastrati A, Dibra A, Eberle S, Mehilli J, Suarez de Lezo J, Goy JJ, et al. Sirolimus-eluting stents vs. paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials. JAMA. 2005;294(7):819–825
  5. Feres F, Munoz JS, Abizaid A, Albertal M, Mintz GS, Staico R, et al. Comparison between sirolimus-eluting stents and intracoronary catheter-based Beta radiation for the treatment of in-stent restenosis. Am J Cardiol. 2005;96(12):1656–1662

PII: S1443-9506(06)00190-9

doi: 10.1016/j.hlc.2006.08.004

Heart, Lung and Circulation
Volume 16, Issue 1 , Pages 50-51 , February 2007

Article Tools

* Image Usage & Resolution